评估plecanatide的现实安全性:基于FDA不良事件报告系统的药监测研究
Zhiyuan Zhang1,2, Yifan Yao2, Li Zhu1,2
1The Second Clinical College of Dalian Medical University, Dalian Medical University, Dalian, Liaoning, China.
Frontiers in pharmacology
|December 10, 2024
概括
现实世界的数据揭示了plecanatide的新安全信号,这是一种治疗慢性异常性便秘 (CIC) 和带便秘的刺激性肠综合征 (IBS-C) 的药物. 大多数不良事件,包括腹和腹部张张,发生在治疗的第一周内.
科学领域:
- 胃肠病学 胃肠病学
- 药物监督 药物监督 药物监督
- 临床安全 临床安全
背景情况:
- 普莱卡纳提德是一种选择性胃肠类药物.
- 它用于慢性异常性便秘 (CIC) 和带便秘的刺激性肠综合征 (IBS-C).
- 鉴于其广泛应用,了解普莱卡纳提德在实际使用中的长期安全性至关重要.
研究的目的:
- 为了评估plecanatide的现实安全概况.
- 为了识别与plecanatide治疗相关的潜在不良事件信号.
- 评估与plecanatide相关的不良事件的时间趋势.
主要方法:
- 利用了来自FDA不良事件报告系统 (FAERS) 的数据,涵盖2017年第一季度至2024年第二季度.
- 采用不相称性分析来检测不良事件信号.
- 进行了用于时间评估的韦布尔分布分析和用于强度的灵敏度分析.
主要成果:
- 鉴定了861个病例和2057份关于plecanatide的不良事件报告.
- 常见的不良事件包括腹,便秘,腹部膨胀和胃肠运动障碍.
- 大多数不良事件在普莱卡纳提德治疗的最初7天内报告.
结论:
- 这项研究突出显示了在现实环境中对plecanatide的显著新不良事件信号.
- 这些发现强调了监测普莱卡纳提德的安全概况的重要性.
- 为医疗保健提供者提供必要的安全信息,为CIC和IBS-C处方plecanatide.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
相关概念视频
01:19Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
01:11Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
01:28Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:12Analysis of Population Pharmacokinetic Data
232
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
232